Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elle Levit

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Multiple Sclerosis and Related Disorders|February 24, 2023
A retrospective evaluation of seroconversion after COVID-19 during the early Omicron wave in fully vaccinated multiple sclerosis patients receiving anti-CD20 therapiesSharon Stoll, Shree Desai, Elle Levit
Neurology|March 20, 2023
Pearls & Oy-sters: Homozygous Complement Factor I Deficiency Presenting as Fulminant Relapsing Complement-Mediated CNS VasculitisElle Levit, Janice Leon, Matthew R Lincoln
Multiple Sclerosis and Related Disorders|March 11, 2022
Seroconversion after COVID-19 vaccination for multiple sclerosis patients on high efficacy disease modifying medicationsElle Levit, Erin E Longbrake, Sharon S Stoll
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 23, 2020
Brainstem lesions are associated with sleep apnea in multiple sclerosisElle Levit, Andrew Bouley, Ursela Baber, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 29, 2025
Evaluation of the relationship between brainstem lesions and apnea hypopnea index in patients with multiple sclerosisElle Levit, Inessa Cohen, Amit Mahajan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 27, 2024
Trigeminal neuralgia within the disease course of MS: Diagnostic and therapeutic implications from a multicenter cohortSini M Laakso, Jiwon Oh, Fasna Raufdeen, et al.
JMIR Public Health and Surveillance|February 6, 2024
Impact of the COVID-19 Pandemic on the Personal Networks and Neurological Outcomes of People With Multiple Sclerosis: Cross-Sectional and Longitudinal Case-Control StudyClaire Riley, Shruthi Venkatesh, Amar Dhand, et al.
Multiple Sclerosis and Related Disorders|October 25, 2022
Impact of resilience, social support, and personality traits in patients with neuroinflammatory diseases during the COVID-19 pandemicDejan Jakimovski, Katelyn S Kavak, Erin E Longbrake, et al.
Multiple Sclerosis and Related Disorders|January 11, 2022
Worsening physical functioning in patients with neuroinflammatory disease during the COVID-19 pandemicElle Levit, Inessa Cohen, Megan Dahl, et al.
Multiple Sclerosis and Related Disorders|December 19, 2021
Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability DataSamantha Epstein, Zongqi Xia, Annie J Lee, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Multiple Sclerosis and Related Disorders|February 24, 2023
A retrospective evaluation of seroconversion after COVID-19 during the early Omicron wave in fully vaccinated multiple sclerosis patients receiving anti-CD20 therapiesSharon Stoll, Shree Desai, Elle Levit
Neurology|March 20, 2023
Pearls & Oy-sters: Homozygous Complement Factor I Deficiency Presenting as Fulminant Relapsing Complement-Mediated CNS VasculitisElle Levit, Janice Leon, Matthew R Lincoln
Multiple Sclerosis and Related Disorders|March 11, 2022
Seroconversion after COVID-19 vaccination for multiple sclerosis patients on high efficacy disease modifying medicationsElle Levit, Erin E Longbrake, Sharon S Stoll
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 23, 2020
Brainstem lesions are associated with sleep apnea in multiple sclerosisElle Levit, Andrew Bouley, Ursela Baber, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 29, 2025
Evaluation of the relationship between brainstem lesions and apnea hypopnea index in patients with multiple sclerosisElle Levit, Inessa Cohen, Amit Mahajan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 27, 2024
Trigeminal neuralgia within the disease course of MS: Diagnostic and therapeutic implications from a multicenter cohortSini M Laakso, Jiwon Oh, Fasna Raufdeen, et al.
JMIR Public Health and Surveillance|February 6, 2024
Impact of the COVID-19 Pandemic on the Personal Networks and Neurological Outcomes of People With Multiple Sclerosis: Cross-Sectional and Longitudinal Case-Control StudyClaire Riley, Shruthi Venkatesh, Amar Dhand, et al.
Multiple Sclerosis and Related Disorders|October 25, 2022
Impact of resilience, social support, and personality traits in patients with neuroinflammatory diseases during the COVID-19 pandemicDejan Jakimovski, Katelyn S Kavak, Erin E Longbrake, et al.
Multiple Sclerosis and Related Disorders|January 11, 2022
Worsening physical functioning in patients with neuroinflammatory disease during the COVID-19 pandemicElle Levit, Inessa Cohen, Megan Dahl, et al.
Multiple Sclerosis and Related Disorders|December 19, 2021
Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability DataSamantha Epstein, Zongqi Xia, Annie J Lee, et al.
Pageof 2